University of Colorado Anschutz Medicl Campus
Aurora, Colorado, 80045, United States
NCT Number: NCT06291090
The investigators implemented a multi-site hospital-based opioid use disorder (OUD) treatment intervention across 12 hospitals in Colorado to address an OUD treatment gap among hospitalized adults with OUD.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Interventional
Not applicable
Aurora, Colorado, 80045, United States
The investigators implemented a multi-site hospital-based opioid use disorder (OUD) treatment intervention across 12 hospitals in Colorado to address an OUD treatment gap among hospitalized adults with OUD. The intervention included nurse driven universal screening for unhealthy substance use with a social work referral for a brief intervention when indicted, electronic health record-embedded protocols to assess for opioid withdrawal and to direct buprenorphine initiation, methadone orders for opioid withdrawal symptoms, and embedded links for post discharge addiction treatment referral. It also included clinician education and nursing education via video conference or in-person lectures. The intervention was supported by the health system Chief Medical Officer and involved subject matters expertise and representation from nursing leaders, social work leaders, and hospital medicine leaders. Outcomes assess include a pre/post implementation assessment of 1) change in buprenorphine prescribed in hospital and 2) discharge, 3) change in naloxone prescribed, 4) change in hospital based methadone prescribing, and 5) change in average clinical opioid withdrawal scale (COWS) score. investigators also assessed a pre/post survey of hospitalists physicians and advanced practice providers to assess their perception of hospital based OUD treatment provision.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants received education on the diagnosis and management of OUD, have access to protocols to walk them through assessment of OUD using Diagnostic and Statistical Manual, fifth Edition (DSM)-5, COWS score to calculate severity of opioid withdrawal, buprenorphine or methadone initiation with pre-populated orders, and clickable links for OUD treatment referral post discharge.
Time frame: Calculate monthly prescribing rates over a three year time frame (including pre and post implementation) to assess for change
Change in rate of buprenorphine prescribing at hospital discharge among patients with OUD before and after intervention implementation
Time frame: Calculate monthly prescribing rates over a three year time frame (including pre and post implementation) to assess for change
Change in rate of in hospital methadone prescribing among patients with OUD before and after intervention implementation
Time frame: Calculate mean monthly COWS scores over a three year time frame (including pre and post implementation) to assess for change
Change in rate of in mean COWS score among patients with OUD before and after intervention implementation
Time frame: Calculate monthly prescribing rates over a three year time frame (including pre and post implementation) to assess for change
Change in rate of naloxone prescribing at hospital discharge among patients with OUD before and after intervention implementation
University of Colorado, Denver
Other
In Hospital Treatment of Opioid Use Disorder: Clinician Perspectives and Current Practices
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07549126
Chemically-Induced Disorders, Clinical Decision Support
Guilford, Connecticut, United States
View Trial DetailsNCT05109429
Chemically-Induced Disorders, Measure Development
Baltimore, Maryland, United States
View Trial DetailsNCT05459922
Chemically-Induced Disorders, Mental Disorders
Phoenix, Arizona, United States
View Trial DetailsNCT05853289
Chemically-Induced Disorders, Mental Disorders
Baltimore, Maryland, United States
View Trial Details